Viewing Study NCT05309304


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-26 @ 2:07 PM
Study NCT ID: NCT05309304
Status: COMPLETED
Last Update Posted: 2022-10-12
First Post: 2022-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cefazolin PK Study 3g vs 2g
Sponsor: Baxter Healthcare Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module